Search Results - Sara García Agudo
- Showing 1 - 1 results of 1
-
1
Nintedanib in combination with docetaxel for second-line treatment of advanced non-small-cell lung cancer; GENESIS-SEFH drug evaluation report by María Espinosa Bosch, Rocío Asensi Diez, Sara García Agudo, Ana Clopes Estela
Published 2016Call Number: Loading…Connect to this object online.
Located: Loading…
Book